-
- 抗原 See all CEBPB 抗体
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
-
抗原表位
- pThr235
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CEBPB antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- 交叉反应
- 人, 小鼠, 大鼠
- 纯化方法
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 免疫原
- Synthesized peptide derived from Human C/EBP beta around the phosphorylation site of T235.
- 亚型
- IgG
- Top Product
- Discover our top product CEBPB Primary Antibody
-
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (N-Term) antibody
KO Validated CEBPB 适用: 人 WB, IHC, IHC (p), IF, IP, ICC, ChIP 宿主: 兔 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (pThr235) antibodyCEBPB 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (Internal Region) antibodyCEBPB 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 150-250) antibodyCEBPB 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) antibodyCEBPB 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 3H9 unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 271-298) antibodyCEBPB 适用: 人 WB, ELISA, IHC, FACS 宿主: 兔 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 68-81) antibodyVerified CEBPB 适用: 人, 小鼠, Pig WB, ELISA 宿主: 山羊 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 271-298), (C-Term) antibodyCEBPB 适用: 人 WB, IHC (p), FACS 宿主: 兔 Polyclonal RB20651 unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (AA 201-250), (pThr235) antibodyCEBPB 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (pSer235) antibodyCEBPB 适用: 人, 小鼠, 大鼠, Cow, Pig WB, IHC, IF, IC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
- 别名
- CEBPB (CEBPB 产品)
- 别名
- C/EBPbeta antibody, c/ebp-beta antibody, crp2 antibody, il6dbp antibody, lap antibody, nf-il6 antibody, tcf5 antibody, xC/EBPbeta antibody, cebpbb antibody, cb380 antibody, c/ebpb antibody, fe11e05 antibody, wu:fe11e05 antibody, CEBPB antibody, LOC100136165 antibody, C/EBP-beta antibody, CRP2 antibody, IL6DBP antibody, LAP antibody, NF-IL6 antibody, TCF5 antibody, IL-6DBP antibody, LIP antibody, NF-M antibody, Nfil6 antibody, Il6dbp antibody, CCAAT/enhancer binding protein beta antibody, CCAAT/enhancer binding protein beta L homeolog antibody, CCAAT/enhancer binding protein (C/EBP), beta antibody, CCAAT/enhancer-binding protein beta antibody, cebpb antibody, cebpb.L antibody, CEBPB antibody, LOC100136165 antibody, Cebpb antibody
- 背景
- AGP/EBP antibody, C EBP beta antibody, C/EBP beta antibody, C/EBP related protein 2 antibody, CCAAT Enhancer Binding Protein beta antibody, CCAAT/enhancer-binding protein beta antibody, CEBPB antibody, CEBPB_HUMAN antibody, CRP2 antibody, IL 6DBP antibody, IL6DBP antibody, Interleukin 6 dependent binding protein antibody, LAP antibody, Liver activator protein antibody, Liver enriched transcriptional activator antibody, NF IL6 antibody, NFIL6 antibody, Nuclear factor NF IL6 antibody, Nuclear factor NF-IL6 antibody, SF B antibody, SFB antibody, Silencer factor B antibody, TCF-5 antibody, TCF5 antibody, Transcription factor 5 antibody
- UniProt
- P17676
- 途径
- Interferon-gamma Pathway, Autophagy, Brown Fat Cell Differentiation
-
You are here:
